Quick Answer
BioAtla, Inc. reported Shares Outstanding of 63.46 million shares for fiscal year 2025.
BioAtla, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 63.46M | +9.2% |
| 2024 | 58.10M | +20.8% |
| 2023 | 48.08M | +3.8% |
| 2022 | 46.34M | +29.4% |
| 2021 | 35.80M | +11.3% |
| 2020 | 32.17M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 58.79M | +21.6% | +0.1% |
| June 30, 2025 | 58.72M | +21.5% | +0.5% |
| March 31, 2025 | 58.40M | +21.4% | +0.5% |
| December 31, 2024 | 58.10M | +20.8% | +20.2% |
| September 30, 2024 | 48.35M | +0.9% | +0.0% |
| June 30, 2024 | 48.33M | +1.1% | +0.5% |
| March 31, 2024 | 48.11M | +1.0% | +0.1% |
| December 31, 2023 | 48.08M | +3.8% | +0.4% |
- BioAtla, Inc. showed an increase of +9.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, BioAtla, Inc.’s shares outstanding has grown by 97.3% (from 32.17 million shares to 63.46 million shares).
- The most recent figure is from BioAtla, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: